VAXCYTE INC. - COMMON STOCK

88.54

22-November-24 16:44:58

15 minutes delayed

Stocks

+0.15

+0.17%

Today's range

87.94 - 91.32

ISIN

N/A

Source

NASDAQ

Vaxcyte Reports First Quarter 2021 Financial Results and Provides Business Update

11 May 2021 16:10:00 By Nasdaq GlobeNewswire
Vaxcyte Announces Publication of Preclinical Data Supporting the Potential of VAX-24 for the Prevention of Invasive Pneumococcal Disease

10 May 2021 08:30:00 By Nasdaq GlobeNewswire
Vaxcyte to Present at BofA Securities 2021 Health Care Conference

06 May 2021 16:05:02 By Nasdaq GlobeNewswire
Vaxcyte to Present at 20th Annual Needham Virtual Healthcare Conference

05 Apr 2021 16:30:00 By Nasdaq GlobeNewswire
Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

29 Mar 2021 16:10:00 By Nasdaq GlobeNewswire
Vaxcyte to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021

22 Mar 2021 16:05:00 By Nasdaq GlobeNewswire
Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections

06 Jan 2021 08:15:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
5
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.